Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, AL 36104, USA.
Department of Zoology, University of Lucknow, Lucknow, Uttar Pradesh 226007, India.
Immunol Lett. 2024 Aug;268:106883. doi: 10.1016/j.imlet.2024.106883. Epub 2024 Jun 8.
The gut microbiota is a system of microorganisms in the human gastrointestinal (GI) system, consisting of trillions of microorganisms residing in epithelial surfaces of the body. Gut microbiota are exposed to various external and internal factors and form a unique gut-associated immunity maintained through a balancing act among diverse groups of microorganisms. The role of microbiota in dysbiosis of the gut in aiding prostate cancer development has created an urgency for extending research toward comprehension and preventative measures. The gut microbiota varies among persons based on diet, race, genetic background, and geographic location. Bacteriome, mainly, has been linked to GI complications, metabolism, weight gain, and high blood sugar. Studies have shown that manipulating the microbiome (bacteriome, virome, and mycobiome) through the dietary intake of phytochemicals positively influences physical and emotional health, preventing and delaying diseases caused by microbiota. In this review, we discuss the wealth of knowledge about the GI tract and factors associated with dysbiosis-mediated compromised gut immunity. This review also focuses on the relationship of dysbiosis to prostate cancer, the impact of microbial metabolites short-chain fatty acids (SCFAs) on host health, and the phytochemicals improving health while inhibiting prostate cancer.
肠道微生物群是人体胃肠道(GI)系统中的微生物系统,由居住在身体上皮表面的数万亿微生物组成。肠道微生物群暴露于各种外部和内部因素,并通过不同微生物群体之间的平衡作用形成独特的与肠道相关的免疫。微生物群在协助前列腺癌发展的肠道失调中的作用,促使人们迫切需要开展研究以加深理解并采取预防措施。肠道微生物群因饮食、种族、遗传背景和地理位置的不同而在个体之间存在差异。主要是细菌组与 GI 并发症、代谢、体重增加和高血糖有关。研究表明,通过摄入植物化学物质来操纵微生物组(细菌组、病毒组和真菌组)可积极影响身心健康,预防和延缓由微生物群引起的疾病。在这篇综述中,我们讨论了有关 GI 道及其与失调介导的肠道免疫受损相关因素的丰富知识。这篇综述还重点介绍了失调与前列腺癌的关系、微生物代谢物短链脂肪酸(SCFAs)对宿主健康的影响,以及抑制前列腺癌同时改善健康的植物化学物质。
Immunol Lett. 2024-8
Cochrane Database Syst Rev. 2022-9-20
Cell Commun Signal. 2025-7-26
Cochrane Database Syst Rev. 2025-7-10
Front Cell Infect Microbiol. 2025-5-21
Vaccines (Basel). 2024-8-1
BMC Pediatr. 2023-10-16